A study reported by AMedNews shows that when the FDA warns doctors about unexpected side effects, doctors do not listen. The study looked at 16 drugs that received new label warnings or were mentioned in “Dear Doctor” letters from 1990 to 2010. The overall result was that doctor’s behavior changed very little. One of the examples that AMedNews cited was atypical antipsychotics where doctors were cautioned to monitor signs of diabetes in their patients. However, rates of blood-sugar testing in those patients did not increase in the time period. To read more about the study, click here. To read more about this article, click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.